Purified cytosolic crystals from Bacillus thuringiensis as a novel active pharmaceutical ingredient (API)
J. Chicca, N. R. Cazeault, F. Rus, A. Abraham, C. Garceau, H. Li, S. M. Atwa, K. Flanagan, E. Soto, M. S. Morrison, D. Gazzola, Y. Hu, D. R. Liu, M. K. Nielsen, J. F. Urban, , R. V. Aroian
This paper describes the scalable purification of Bt Cry5B crystals and demonstrates their potent bioactivity against nematodes in vitro and in vivo.
bioRxiv · May 20, 2022 · PreprintMicrobiology